MIMETAS develops organ-on-a-chip technology for drug screening in 3D-tissues. Our unique microfluidic platform enables testing of compounds in high-throughput on miniaturized organ models. These models offer better predictivity as compared to laboratory animal testing and conventional cell culture models. The MIMETAS OrganoPlate™ platform supports 3D cell culture under continuous perfusion, membrane-free co-culture and boundary- and gradient formation, thus mimicking important aspects of tissues and organs.
Copyright 2014, a2z, Inc. All rights reserved.